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 Abstract 
 Diversity in the genetic profile between individuals and specific ethnic groups affects nutri-
ent requirements, metabolism and response to nutritional and dietary interventions. In-
deed, individuals respond differently to lifestyle interventions (diet, physical activity, smok-
ing, etc.). The sequencing of the human genome and subsequent increased knowledge 
regarding human genetic variation is contributing to the emergence of personalized nutri-
tion. These advances in genetic science are raising numerous questions regarding the mode 
that precision nutrition can contribute solutions to emerging problems in public health, by 
reducing the risk and prevalence of nutrition-related diseases. Current views on personal-
ized nutrition encompass omics technologies (nutrigenomics, transcriptomics, epigenom-
ics, foodomics, metabolomics, metagenomics, etc.), functional food development and chal-
lenges related to legal and ethical aspects, application in clinical practice, and population 
scope, in terms of guidelines and epidemiological factors. In this context, precision nutrition 
can be considered as occurring at three levels: (1) conventional nutrition based on general 
guidelines for population groups by age, gender and social determinants; (2) individualized 
nutrition that adds phenotypic information about the person’s current nutritional status 
(e.g. anthropometry, biochemical and metabolic analysis, physical activity, among others), 
and (3) genotype-directed nutrition based on rare or common gene variation. Research and 
appropriate translation into medical practice and dietary recommendations must be based 
on a solid foundation of knowledge derived from studies on nutrigenetics and nutrigeno-
mics. A scientific society, such as the International Society of Nutrigenetics/Nutrigenomics 
(ISNN), internationally devoted to the study of nutrigenetics/nutrigenomics, can indeed 
serve the commendable roles of (1) promoting science and favoring scientific communica-
tion and (2) permanently working as a ‘clearing house’ to prevent disqualifying logical 
jumps, correct or stop unwarranted claims, and prevent the creation of unwarranted expec-
tations in patients and in the general public. In this statement, we are focusing on the sci-
entific aspects of disciplines covering nutrigenetics and nutrigenomics issues. Genetic 
screening and the ethical, legal, social and economic aspects will be dealt with in subse-
quent statements of the Society.   © 2016 S. Karger AG, Basel 
 Introduction 
 The purpose of the International Society of Nutrigenetics/Nutrigenomics (ISNN) is to 
increase through research the understanding of the role of genetic variation and dietary 
response and the role of nutrients in gene expression among both professionals and the 
general public  [1] .
 The Society is educational in its mission to serve as a focus for communicating among 
interested scientists working in nutrition, genetics, cellular and molecular biology, physi-
ology, pathology, biochemistry, clinical medicine, epidemiology, and public health, who are 
studying the role of genetic variation and dietary response and the role of nutrients in gene 
expression. It is believed that improved communication across these different branches of 
medical and biological sciences will stimulate new research and increase the knowledge of 
gene-nutrient interactions and genetic variation and dietary response. The ISNN will assist in 
interpreting the new facts into sound nutritional advice for the public as well. As needed, the 
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Society will establish committees to handle scientific and educational aspects and develop 
statements to be approved by the Board. 
 A first such statement has been developed on the state of the art of the field of nutrige-
netics/nutrigenomics, focusing on personalized nutrition and biotechnological advances. 
Subsequent statements will be on the ISNN position on genetic testing, ethical, social and legal 
aspects. Some of the statements may be developed in collaboration with other institutes and 
national societies. 
 Personalized Nutrition 
 Individuals respond differently to lifestyle interventions, especially those modulating 
diet, because of genetic variants that influence how dietary components are absorbed, metab-
olized and utilized  [2, 3] . Therefore, dietary advice that is specific to individuals with a 
particular genotype should be more effective at preventing chronic diseases than general 
recommendations about diet  [4] . Some consumer genetic testing companies are beginning to 
provide information as to how diet should be modified, based on the genotype, to prevent 
disease or improve health, i.e. personalized nutrition ( fig. 1 ).
 The sequencing of the human genome and consequent increased knowledge regarding 
human genetic variation is contributing to the emergence of personalized nutrition  [2] . 
Recognition of diverse individual nutritional needs and responses to diet are changing stan-
dards of nutritional care, creating new possibilities for this field. 
 Dietary reference intake values such as recommended dietary allowance and safe upper 
limits established by the Food and Nutrition Board of the National Academy of Medicine are 
based on recommendations for populations rather than for specific individuals or groups of 
individuals  [5] . Some countries emphasize the food guide pyramid of the United States 
Department of Agriculture (USDA)  [6] , or the USDA dietary guidelines  [7] . Promotion of 
dietary patterns believed to be beneficial, such as the Mediterranean diet, is another way to 
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 Fig. 1. Endeavors and achievements already made, plus progress and challenges in current and future sce-
narios with regard to personalized nutrition.  
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express healthy nutrition  [8] . Most dietary recommendations are stratified according to 
gender and age, but these are not the only factors that should be considered when giving 
advice on nutrient intake. Diversity in the genetic profile between individuals and specific 
ethnic groups affects nutrient requirements, metabolism and response to nutritional and 
dietary interventions  [9, 10] .
 Environmental, cultural and economic factors also play a crucial role in individual food 
choices and accessibility  [10] . Malnutrition in the form of undernutrition or obesity can also 
modify gene expression and genome stability, resulting in changes in phenotype, and hence 
it is difficult to choose one population as a reference  [11] . New statistical approaches are 
urgently needed for estimating reference values in different population groups  [12] . Features 
such as age, gender, physical activity, physiological state, social status and special conditions 
such as pregnancy and risk of disease  [13] can inform dietary advice that more closely meets 
individual needs  [14] .
 Improved health care can be achieved if nutritional recommendations are personalized 
according to individual genetic profile, phenotype, health status, food preferences and envi-
ronmental characteristics  [10] . Personalized nutrition is an important part of personalized 
medicine and may assist in establishing guidelines for specific subgroups based on phenotype 
and genotype. 
 The suffix ‘omics’ means ‘global’ and is used as a modifier for a wide range of endeavors 
such as the comprehensive analysis of genes (genomics), DNA modifications (epigenomics), 
messenger RNA (mRNA) or transcripts (transcriptomics), proteins (proteomics), metabolites 
(metabolomics), lipids (lipidomics), food (foodomics) and microbiota (microbiomics, metage-
nomics). All these techniques can be applied separately or in an integrated manner for a 
better understanding of health metabolism and disease progression  [10] . 
 As mentioned already, some ‘omics’ technologies could be used to develop optimal, 
customized diets to promote health maintenance and disease prevention for each individual, 
thus expanding into effective public health strategies on diet therapy  [15, 16] . With this 
perspective, the omics tools most immediately relevant to personalized nutrition include 
nutrigenetics, nutrigenomics and nutriepigenetics. Nutrigenetics investigates the influence of 
the genotype (variants of the DNA sequence) on the response to nutritional change and on 
the risk of nutrition-related disease. Nutrigenomic studies investigate the effect of nutrition 
on gene expression and, consequently, on the proteome and the metabolome  [17] . Nutriepi-
genetic studies explore the chromatin structure and DNA modifications that do not alter the 
underlying DNA sequence, but affect gene expression  [18] . 
 These advances in genetic science are raising numerous questions regarding how person-
alized nutrition can contribute solutions to emerging problems in public health, by reducing 
the risk and prevalence of nutrition-related disease. The availability of genetic information 
also raises questions from health-care professionals as to how to apply such knowledge, and 
from individuals regarding how to use such information. Furthermore, commercialization of 
genetic information raises ethical and moral issues. Hence, the interpretation and inclusion 
of genetic components into nutrition recommendations and products may generate ethical 
and financial difficulties while simultaneously promoting a revolution in nutrition. 
 Genome-wide association studies (GWAS) have identified a large number of genetic 
variants associated with complex diseases and traits  [19] , but have failed to explain a large 
part of their heritability  [20] . GWAS usually measure the impact of genes on disease using 
correlations rather than studying interactions between genes and environmental factors 
such as diet or exercise. These interactions cause genotypic effects to be more pronounced 
under particular environmental conditions. Therefore, failing to control for such variations 
means that GWAS data provide only a partial picture of genetic variation contributing to 
disease development, particularly with regard to heritability  [21] .
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 GWAS should be considered as only a first step in the understanding of the molecular 
basis of complex diseases. The advances in nutrigenetics, nutrigenomics and nutriepigenetics 
will help to identify the variability in interactions not controlled for in GWAS. This situation 
means that new bioinformatics and biostatistics tools will be necessary to make this new 
information useful for health-care professionals  [22] .
 Current views on personalized nutrition encompass omics technologies, functional foods, 
existing products, future challenges – particularly those relating to legal and ethical aspects, 
application in clinical practice, and population scope, in terms of guidelines and epidemio-
logical factors ( fig. 1 ). In this statement, we are focusing on the scientific aspects of disciplines 
covering nutrigenetics and nutrigenomics issues. Genetic screening and the ethical, legal, 
social and economic aspects will be dealt with in subsequent statements of the Society. 
 Omics Technologies in Personalized Nutrition 
 Application of information regarding genes and molecular pathways related to the use 
and metabolism of nutrients is a key approach for personalized nutrition  [23] , the knowledge 
of which is facilitated by the emergence of ‘omics’ technologies.
 Nutrigenetics 
 A major contribution of the Human Genome Project was to lay the foundation that led to 
the discovery of millions of differences in the nucleotide sequence of genes. The variants 
occurring in at least 1% of any distinct population are called polymorphic variants or poly-
morphisms  [23] . A particularly common type of polymorphism is defined by the replacement 
of one nucleotide base with another, and therefore called ‘single nucleotide polymorphism’ 
(SNP). Some SNPs may affect the synthesis and function of proteins, and may therefore alter 
nutritional requirements and nutrient metabolism  [24, 25] , as well as playing important roles 
in an individual’s risk of developing disease  [26] . 
 A further way in which genetic variations occur is through structural DNA changes that 
include insertions/deletions, translocations and copy number variations (CNVs). CNVs 
explain about 1% of the genetic variation between two individuals  [27] . Some of them appear 
to play an important role in human health  [28, 29] through association with the risk of disease 
development and progression  [30] .
 The discovery of diseases associated with genetic variants has provided a better under-
standing of nutrient/diet effects on human health and disease  [10] , and has helped indi-
viduals to achieve customized nutritional treatments. One example of this is phenylketonuria 
(PKU), an inborn error of metabolism caused by mutations in the gene that encodes the 
hepatic enzyme phenylalanine hydroxylase  [31] . Individuals with PKU need to avoid foods 
rich in the amino acid phenylalanine. Another example is lactase persistence, which evolved 
a few thousand years ago in response to the development of dairy farming. Carriers of variants 
associated with lactase persistence have their lactase gene permanently ‘turned on’ after 
weaning and can digest lactose even as adults. Lactose (milk sugar) is a disaccharide, made 
from glucose and galactose. Therefore, the 70% of the global population, who do not have 
such genetic variants, are better off limiting consumption of milk and other dairy products 
rich in lactose  [31] .
 Recent studies investigating genetic variants associated with obesity risk or with resis-
tance to weight loss in human populations  [32, 33] have helped clarify molecular mecha-
nisms involved in obesity  [34] . One such example is the fat mass and obesity-associated 
(FTO) gene. The minority (16%) of individuals with two copies of the common FTO variant 
(rs9939609) weigh around 3 kg more than noncarriers and have a 1.67-fold increased risk 
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of obesity  [35] . Variants in numerous other obesity candidate genes, such as peroxisome 
proliferator-activated receptor, uncoupling proteins (UCP1 and UCP3), leptin receptor and 
melanocortin 4 receptor, can also affect weight gain or loss in genetically predisposed 
subjects  [32, 36] . 
 Variants in genes necessary for lipid metabolism, such as those encoding cholesteryl 
ester transfer protein, lipoprotein lipase, low-density lipoprotein receptor and apolipo-
protein E, may increase the risk of coronary artery disease  [37–40] . Further variants are asso-
ciated with the development of diabetes, cancer and other diseases. Dietary advice specifi-
cally tailored to some of these variants may reduce the elevated disease risk better than 
genetic counselling without knowledge of the genetic information  [41] . 
 Many other metabolic pathways and biological functions have similarly identifiable 
genetic vulnerabilities that are amenable to tailoring of dietary intakes. For example, the 
combination of low folate intake, a low-activity variant of the 5,10-methylene tetrahydro-
folate reductase gene (MTHFR), increases susceptibility to disease, while either of them on 
their own will not  [42, 43] . Technologies such as next-generation sequencing (NGS) platforms 
(arrays, bead chips and sequencing approaches) provide a rapid scan of known genetic 
variants to define genetic differences between individuals  [44, 45] . 
 Assessing the role of single gene variants in complex traits influenced by many genes 
[e.g., diabetes, cancer and cardiovascular disease (CVD)] is difficult for many reasons, but not 
least due to gene-gene interactions. Therefore, simultaneous examination of multiple variants 
is necessary, given the fact that several of them may affect the function of a particular gene 
and that multiple genes may contribute to disease development and progression. This 
approach assists with defining biological response to food components and food patterns, 
thereby advancing strategies to identify, treat and prevent disease  [45] . In particular, the 
analysis of groups of gene variants (haplotypes) that are related or physically close to each 
other on the same DNA strand can promote our understanding of biological events and condi-
tions  [46] .
 Telomere length (TL) has also been linked to the risk of several diseases, such as cancer 
and CVD  [47] . Telomeres are tandem TTAGGG repeats of DNA that, together with associated 
protein factors, protect the ends of chromosomes and become shorter with each round of 
DNA replication  [48] . TL is a biomarker of cumulative oxidative stress, biological age, and an 
independent predictor of survival and therapeutic treatment requirements. Thus, leukocyte 
TL has been proposed as a biomarker of biological age  [47] . Studies have shown that dietary 
patterns can protect or damage telomeres. For example, high consumption of fruits and vege-
tables and a higher intake of omega-3 fatty acids or fiber were associated with longer telo-
meres  [49, 50] , whereas higher intake of saturated fatty acids and higher consumption of 
processed meats were both associated with telomere shortening  [51] . Furthermore, recent 
studies have shown that total dietary antioxidant capacity was associated with longer telo-
meres, while higher white bread consumption was associated with telomere shortening in a 
population of Spanish children and adolescents  [52] .
 Nutrigenomics  
 Nutrients and food components can affect and regulate gene activity both directly and 
indirectly, including acting as ligands of transcription factors and playing a regulatory role in 
intermediate metabolites of signaling pathways, with positive or negative effects  [53] . Hence, 
nutrigenomics seeks to show how dietary factors influence gene expression and subsequently 
impact protein and metabolite levels  [54, 55] . A common approach is the examination of indi-
vidual mRNA levels relative to intake of certain food components. Nutrigenomic strategies 
thus include analysis of gene expression and biochemical profiles. Early examples of such 
research strategies include the finding that dietary cholesterol inhibits transcription of the 
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3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) gene  [56] , and that long-chain omega-3 
polyunsaturated fatty acids reduce gene transcription of platelet-derived growth factor and 
interleukin-1β  [57, 58] . 
 Transcriptomics 
 The study of the transcriptome (the complete set of RNA transcripts)  [23] , provides a tool 
for observing such changes in gene expression in response to different factors including 
dietary changes  [59] . Diet, physical activity, alcohol and smoking habits all modify gene 
expression and consequently affect the risk of pathological outcome  [36, 60] . Dietary compo-
nents, such as macronutrients and micronutrients influence gene expression, thereby altering 
metabolism and the development of disease  [23] . Transcriptome analysis can evaluate the 
expression of thousands of genes before and after dietary intervention, showing the difference 
between healthy and unhealthy individuals and helping to establish new biomarkers for 
disease diagnosis  [23] .
 Transcriptomics requires the study of cells in which genes are expressed, because gene 
expression is often tissue specific. It is difficult to access the most relevant human tissues, 
meaning that samples are usually available only from the more accessible tissues such as 
subcutaneous adipose tissue, blood mononuclear cells and skeletal muscle  [61] . Polymerase 
chain reaction has been used to measure gene expression in the interaction of the genome 
and diet  [31] . Newer microarray technologies can identify most changes in gene expression 
and in metabolic pathways after nutritional intervention.
 Epigenetics/Epigenomics 
 Epigenetic processes bring about reversible modifications in chromatin structure and 
DNA modification without altering the underlying sequence. Epigenetic changes include DNA 
methylation and histone modification  [33, 62, 63] . Different classes of small noncoding RNAs 
(such as microRNAs) or long noncoding RNAs have been proposed as key regulators of gene 
expression, chromatin remodeling and epigenetic changes through multiple mechanism, 
showing a potential as biomarkers of human diseases  [64, 65] . Additionally, external effects 
(including diet) on the epigenome alter the expression of genes, providing a link between 
environment, nutrition and disease  [66] .
 DNA methylation is the most widely studied form of epigenetic modification. One of 
numerous specific methyltransferases adds a methyl group to the cytosine in the carbon 5 ′ 
position of a CpG dinucleotide (cytosine followed by a guanine). The added methyl group 
often silences the gene by blocking the binding of transcription factors  [61, 67] . In recent 
years, development of new technologies such as NGS has allowed the detection of site-specific 
methylation patterns with great accuracy and led to the discovery of new types of epigenetic 
modifications  [68–70] . 
 Histone modifications, consisting of acetylation, methylation, phosphorylation and ubiq-
uitination, affect transcription through compacting DNA. This process can activate or repress 
gene expression by controlling accessibility of genes to transcriptional regulators  [71, 72] .
 Epigenetics depends on the presence of enzymes and dietary nutrients, and can occur in 
a gene-specific or in a global manner  [73] . S-adenosylmethionine (SAM) is the universal 
methyl donor for all methyltransferases that methylate DNA and histones. The availability of 
SAM can be diminished under some circumstances by insufficient availability of folic acid, 
vitamin B 12 , vitamin B 6 , vitamin B 2 , choline, betaine and methionine, both due to low intake 
and individual genetic vulnerabilities  [74, 75] .
 Some studies have shown a relationship between nutritional intake during pregnancy 
and changes in methylation patterns in rats  [76, 77] . Nutritional interventions in pregnancy 
and lactation such as energy restriction and excessive dietary fat can alter epigenetic modifi-
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cations  [78] . Other studies have shown that epigenetic modifications change the risk of 
inflammation, obesity and chronic diseases  [79] . A study of obese men on a hypocaloric diet 
to lose weight found distinct differences in DNA methylation patterns between individuals 
with high weight loss compared to those with little weight loss  [80] . Studies in diabetic indi-
viduals found associations between the secretion of insulin and the DNA methylation pattern 
in the promoter region of the PCG-1A gene of pancreatic β-cells  [81] .
 New NGS and microarray technologies have enabled the study of DNA methylation at 
high resolution across the genome, helping to characterize epigenetic outcomes though epi-
genome-wide association studies  [82] . 
 Proteomics  
 Transcriptomics does not show the number of expressed proteins. Thus, one transcript 
can be translated into numerous proteins, just as many factors can stop or modify the trans-
lation process or cause posttranslational modifications  [6] . Proteomics analyzes protein
expressed over a given time, and is the most precise method for identifying the effect of nu-
trients and food components on the genome  [6, 23] .
 Each cell will have a corresponding proteome, depending on the cell’s type and function 
 [83] . Proteins are commonly analyzed in blood samples  [84] , but there is not a single platform 
capable of evaluating the full spectrum of proteins in blood or tissue samples  [85] .
 Lipidomics 
 Lipids play an important role in nutrition and metabolism  [86] . Lipidomics produces a 
global profile of lipids found in cells, tissues and fluids  [87] , studying the interactions between 
genes, diet, nutrients and human metabolism  [86, 88] . It is an emerging tool for identifying 
individual variability in response to nutritional interventions, and can be used in diet coun-
seling and to optimize food processing  [86] . Lipidomic studies are possible due to advances 
in mass spectrometry technologies  [89] . Use of lipidomics in clinical practice is still in its 
infancy, because the knowledge of lipid metabolism pathways is incomplete and needed tools 
continue to evolve  [90] .
 Metabolomics 
 Metabolomics studies metabolites in human systems  [83] , focusing on changes in the 
biochemical profile of biological fluids, blood, urine, saliva, cells and tissues  [91] . Some 
authors have proposed a new term, ‘nutrimetabolomics’, meaning the application of metabo-
lomics in nutrition and health  [91, 92] . 
 Metabolomic studies can evaluate groups of metabolites related to a specific metabolic 
pathway or compare modifications in patterns of metabolites in response to environmental 
stimuli  [93] following targeted or untargeted approaches. Thus, metabolomics is considered 
the end point of human molecular analysis  [94] and can assess the body’s response to a diet. 
Many studies have used metabolic profiling to identify food biomarkers and to define dietary 
patterns. Other applications of metabolomics include monitoring of food consumption and 
assessment of food quality  [95] . Hence, metabolomics can answer questions such as how a 
high-saturated fat diet can affect lipid profile, or how the intake of fiber affects glycemia. 
Recent dietary intervention studies using metabolic profiles have evaluated the conse-
quences of consuming cocoa  [96] , coffee  [97] and fiber  [98] , and of different dietary patterns 
 [99] .
 Study of metabolites is only possible with advances in techniques that separate and 
identify small molecules  [100] . However, there is not yet a methodology capable of detecting, 
identifying and quantifying all human metabolites. Combining techniques such as system-
based mass spectrometry, nuclear magnetic resonance, gas chromatography and liquid chro-
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matography may be a better approach for global metabolite identification  [93] . As with GWAS, 
many chemicals and metabolites can be tested for and associated with diet and disease  [16] 
through metabolome-wide studies.
 Foodomics 
 Foodomics refers to a new science that evaluates food components using new technol-
ogies, with the aim of improving human health through improving human nutrition  [101, 
102] . In recent years, food scientists have developed new products, packaging and sensory 
characteristics to better reach target markets  [101] . Study of the molecular composition of 
foods enables such breakthroughs.
 Foods originate from living things (animals, plants or fungi) and are affected by agricul-
tural and production technologies. Food composition depends on many factors such as 
season, maturation and temperatures of storage and cooking. Foodomics can help solve 
problems related to food safety, food quality, new foods, transgenic foods and functional 
foods  [103, 104] , improving dietary constituents and thereby better enabling disease pre-
vention through diet. 
 Foodomics evaluates the effects of food components at the level of genome, transcriptome, 
proteome and metabolome, thus providing additional studies of bioactive compounds in food 
at the molecular level  [85] . However, variability and differing concentrations of nutrients and 
bioactive food compounds create limitations in foodomics studies  [93] . 
 Examples of foodomics strategies include the study of oligosaccharides, phytochemicals, 
antioxidants, bioactive compounds, biotoxins and other factors  [105] . Mass spectrometry-
based techniques, new separation methods and multidimensional chromatographic tech-
niques have been used in food composition analysis  [105] .
 One complete, multidimensional definition of foodomics is that of a science that studies 
the role of biomarkers, food components, diets and lifestyle in reaching and maintaining 
health and wellness  [106] .
 Metagenomics 
 Metagenomics refers to studies of the global microbial communities, and their genes 
present in the gut and other body parts  [107, 108] . Microbiota are able to alter gene expression, 
affecting the proteome and the health of an individual. Thus, they can be viewed as further 
functional, genomic units which regulate metabolic processes  [107, 109] . Many food constit-
uents, such as polyphenols, fiber and fat, affect the microbiota in the gut and thereby can have 
microbiome-mediated effects.
 Products of microbial fermentation such as short-chain fatty acids may have a direct 
effect on cellular metabolism  [110] . Dysbiosis can result in inflammation in the luminal gut, 
contributing to risk and development of diseases  [111] including obesity  [111–113] , diabetes 
and atherosclerosis  [114, 115] , Crohn’s disease  [116] , gastritis and gastrointestinal cancer 
 [117] and food allergies  [118] . Recent studies have associated nutrition during gestation and 
childhood with effects on the microbiota, and subsequent effects on immune function and 
immunocompetence to the onset of obesity and other chronic diseases  [119] .
 Different dietary components have distinct roles in microbial growth and may modulate 
functions of the intestinal microbiome  [120] ; for example, the ingestion of phenolic compounds 
may modulate the microbiota, promoting the growth of beneficial bacteria  [121] . The effect 
of diet on the microbiome depends on the age and environment of the individual  [122] , and 
on the genetic characteristics of the host  [123, 124] . Microbial exposure during pregnancy 
and the composition of gut microbiota during the first months of life influence immune 
function and predisposition to allergy  [125] . 
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 The gut microbiome can also be associated with the progression of CVD, acting in the 
conversion of choline and  L -carnitine present in the diet to trimethylamine and trimethyl-
amine-N-oxide compounds  [126] . CVD risk is associated with inflammation, risk of obesity 
and diabetes; thus, novel strategies of gut microbiome manipulation could lead to improve-
ments in the treatment of CVD and obesity  [126] .
 The gut microbiota are unique to each individual; consequently, the microbiome is 
emerging as a tool for personalized nutrition  [127] . These new findings promote an alter-
native approach to regulation of gene expression through diet and food components. New 
technologies for analyzing the gut microbiome are needed, however, before metagenomics 
can usefully contribute to personalized nutrition  [127] .
 Precision Nutrition 
 The response of an individual to nutrient intake results from the interaction of metabolic, 
environmental, social and genetic factors ( fig. 2 ). Analysis of an individual’s genome can 
distinguish responders from nonresponders to dietary interventions and treatments. Person-
alized nutrition depends on the genetic background plus biological and cultural variations, 
including food intolerances, preferences and allergies  [33] , where knowledge and integration 
will allow precision nutrition.
 The traditional concept of personalized nutrition is to adapt the diet according to indi-
vidual needs and preferences  [128] . With the evolution of high-throughput technologies, 
precision nutrition can finally contribute to the reduction and prevention of disease by using 
genetic information to predict whether someone is going to respond to specific nutritional 
patterns or not  [129] . Personalized nutrition is based on the principle that particular foods 
or nutrient quantities may alter disease risk more or less, depending on the individual’s DNA 
sequence  [130] .
 Precision nutrition can be considered as occurring at three levels: (1) conventional 
nutrition based on general guidelines for population groups by age, gender and social deter-
minants; (2) individualized nutrition that adds phenotypic information about the person’s 
current nutritional status (e.g. anthropometry, biochemical and metabolic analysis, physical 
activity, among others), and (3) genotype-directed nutrition based on rare or common gene 
variation  [131] . The ultimate goal is to integrate such sources of information to ensure that 
Personalized
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 Fig. 2. The interplay between ge-
netic background, biological, cul-
tural and environmental varia-
tions on personalized nutrition. 
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health-care professionals, including dietitians, physicians, pharmacists and genetic coun-
selors, know sufficient concepts about nutrigenetics and nutrigenomics to decide on the most 
appropriate level of care to achieve a precision nutrition which integrates phenotypical and 
genotypical issues as well as social, environmental and metabolic factors  [132–134] .
 Conclusions 
 The use of new technologies is paving the way for solid individual nutritional recommen-
dations with important challenges concerning strengthening the science, training personnel 
and improving knowledge delivery and public education ( table 1 ). It is important that future 
studies utilize outcome research, not only considering the effects of a nutritional intervention 
on surrogate parameters in different genetic groups, but also looking at effects on disease 
development, survival and quality of life. This recognizes that recommendations based on the 
analysis of intermediate end points can be highly biased and potentially counteracted by 
opposite effects on some other intermediate end point that was not directly estimated in the 
investigation. The road ahead for the discipline must involve the integration of several 
different fields of study in order to formulate solid individualized nutritional recommenda-
tions.
 Like drugs, nutrients have the ability to interact and modulate molecular mechanisms 
underlying an organism’s physiological functions. Awareness of the different effects of nu-
trients according to our genetic constitution (nutrigenetics) and how nutrients may affect 
gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutri-
1. Strengthening the science
a Creation of risk map
b Creation of a reliable ‘bank’ of polymorphisms
c Tests  of epigenetic assessment
d Identification of valid biomarkers
e Microbiome and lipidomics studies
f Implementation into public health policies
g Metagenomics view
h Development of new technologies (bioinformatics) for analyzing 
data
i Applicability to clinical practice
j Tools for evaluating diet in nutrigenomic studies
k Regulation of ethical and legal aspects
l Cost reduction
2. Training personnel and improving knowledge delivery
a Increasing availability of trained allied health professionals 
capable of interpreting genetic data
b Greater involvement of dietetic professionals in dietary 
recommendations
c Promoting introduction of nutrigenomic education into the 
curricula of allied health professionals
d Promoting introduction of nutrigenomic education into medical 
curricula
3. Public education
a Communication with and involvement of science writers
b Dissemination of ‘lay’ information via mainstream media in the 
form of print, screen and social media
 Table 1. Major challenges of 
personalized nutrition
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tional sciences have traditionally studied the effects of nutrients in terms of ‘average’ 
responses, largely without considering interindividual variability and the underlying causes. 
Advances in nutrigenetics and nutrigenomics, with distinct approaches to elucidate the inter-
action between diet and genes, but with the common ultimate goal of optimizing health 
through personalized diet, provide powerful approaches to unravel the complex relation-
ships between nutritional molecules, genetic variants and the biological system. Translated 
as the simple concept of ‘personalized nutrition’, the promise of nutrigenetics/nutrigenomics 
is a major step forward in the understanding of individual responses to a component nutrient 
or to our changing environment for precision nutrition. 
 A scientific society, such as the ISNN, internationally devoted to the study of nutrigenetics 
and nutrigenomics can indeed serve the commendable roles of (1) promoting science and 
favoring scientific communication, and (2) permanently working as a ‘clearing house’ to 
prevent disqualifying logical jumps, correct or stop unwarranted claims, and prevent the 
creation of unwarranted expectations in patients and in the general public. Research and 
appropriate translation into medical practice and dietary recommendations must be based 
on a solid foundation of knowledge derived from studies on nutrigenetics and nutrigenomics.
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